Abstract:Background Prenatal adverse environments can cause fetal intrauterine growth retardation (IUGR) and higher susceptibility to multiple diseases after birth, related to multi-organ development programming changes mediated by intrauterine overexposure to maternal glucocorticoids. As a glucocorticoid barrier, P-glycoprotein (P-gp) is highly expressed in placental syncytiotrophoblasts; however, the effect of P-gp on the occurrence of IUGR remains unclear. Methods Human placenta and fetal cord blood samples of IUGR fetuses were collected, and the related indexes were detected. Pregnant Wistar rats were administered with 30 mg/kg center dot d (low dose) and 120 mg/kg center dot d (high dose) caffeine from gestational day (GD) 9 to 20 to construct the rat IUGR model. Pregnant mice were administered with caffeine (120 mg/kg center dot d) separately or combined with sodium ferulate (50 mg/kg center dot d) from gestational day GD 9 to 18 to confirm the intervention target on fetal weight loss caused by prenatal caffeine exposure (PCE). The fetal serum/placental corticosterone level, placental P-gp expression, and related indicator changes were analyzed. In vitro, primary human trophoblasts and BeWo cells were used to confirm the effect of caffeine on P-gp and its mechanism. Results The placental P-gp expression was significantly reduced, but the umbilical cord blood cortisol level was increased in clinical samples of the IUGR neonates, which were positively and negatively correlated with the neonatal birth weight, respectively. Meanwhile, in the PCE-induced IUGR rat model, the placental P-gp expression of IUGR rats was decreased while the corticosterone levels of the placentas/fetal blood were increased, which were positively and negatively correlated with the decreased placental/fetal weights, respectively. Combined with the PCE-induced IUGR rat model, in vitro caffeine-treated placental trophoblasts, we confirmed that caffeine decreased the histone acetylation and expression of P-gp via RYR/JNK/YB-1/P300 pathway, which inhibited placental and fetal development. We further demonstrated that P-gp inducer sodium ferulate could reverse the inhibitory effect of caffeine on the fetal body/placental weight. Finally, clinical specimens and other animal models of IUGR also confirmed that the JNK/YB-1 pathway is a co-regulatory mechanism of P-gp expression inhibition, among which the expression of YB-1 is the most stable. Therefore, we proposed that YB-1 could be used as the potential early warning target for the opening of the placental glucocorticoid barrier, the occurrence of IUGR, and the susceptibility of a variety of diseases. Conclusions This study, for the first time, clarified the critical role and epigenetic regulation mechanism of P-gp in mediating the opening mechanism of the placental glucocorticoid barrier, providing a novel idea for exploring the early warning, prevention, and treatment strategies of IUGR.

Maternal Glucocorticoid Elevation and Associated Blood Metabonome Changes Might Be Involved in Metabolic Programming of Intrauterine Growth Retardation in Rats Exposed to Caffeine Prenatally

Fetal Rat Metabonome Alteration by Prenatal Caffeine Ingestion Probably Due to the Increased Circulatory Glucocorticoid Level and Altered Peripheral Glucose and Lipid Metabolic Pathways.

Caffeine-induced Fetal Rat Over-Exposure to Maternal Glucocorticoid and Histone Methylation of Liver IGF-1 Might Cause Skeletal Growth Retardation.

Prenatal caffeine ingestion induces transgenerational neuroendocrine metabolic programming alteration in second generation rats

Maternal and fetal metabonomic alterations in prenatal nicotine exposure-induced rat intrauterine growth retardation.

Correction To: P-gp Expression Inhibition Mediates Placental Glucocorticoid Barrier Opening and Fetal Weight Loss.

P-gp expression inhibition mediates placental glucocorticoid barrier opening and fetal weight loss

Intrauterine Programming of Glucocorticoid–Insulin-Like Growth Factor-1 Axis–Mediated Developmental Origin of Osteoporosis Susceptibility in Female Offspring Rats with Prenatal Caffeine Exposure

Effects of Prenatal Caffeine Exposure on Glucose Homeostasis of Adult Offspring Rats

Prenatal Caffeine Exposure Induces Liver Developmental Dysfunction in Offspring Rats.

Intrauterine Endogenous High Glucocorticoids Program Ovarian Dysfunction in Female Offspring Secondary to Prenatal Caffeine Exposure

Caffeine Consumption During Early Pregnancy Impairs Oviductal Embryo Transport, Embryonic Development and Uterine Receptivity in Mice†

Glucocorticoid Mediates Prenatal Caffeine Exposure-Induced Endochondral Ossification Retardation and Its Molecular Mechanism in Female Fetal Rats

Intrauterine Programming Mechanism for Hypercholesterolemia in Prenatal Caffeine-Exposed Female Adult Rat Offspring.

The upregulation of glutamate decarboxylase 67 against hippocampal excitability damage in male fetal rats by prenatal caffeine exposure

Gender-specific Increase in Susceptibility to Metabolic Syndrome of Offspring Rats after Prenatal Caffeine Exposure with Post-Weaning High-Fat Diet.

Maternal low-dose caffeine intake during the perinatal period promotes short- and long-term sex-dependent hormonal and behavior changes in the offspring

The GC-IGF1 axis-mediated testicular dysplasia caused by prenatal caffeine exposure.

Intrauterine Metabolic Programming Alteration Increased Susceptibility to Non-Alcoholic Adult Fatty Liver Disease in Prenatal Caffeine-Exposed Rat Offspring

Behavioral, genetic and biochemical changes in the brain of the offspring of female mice treated with caffeine during pregnancy and lactation

Prenatal Caffeine Exposure Induced High Susceptibility to Metabolic Syndrome in Adult Female Offspring Rats and Its Underlying Mechanisms.